Business

CTP builds 18,000 sqm Serbian facility for SCHOTT Pharma as it expands global manufacturing network

AMSTERDAM, May 19, 2025--Regulatory News: CTP, Europe's largest listed developer, owner, and manager of industrial and logistics properties by gross lettable area (GLA), has developed a new 18,000 sqm build-to-suit production facility for SCHOTT Pharma, a pioneer in pharma drug containment solutions and delivery systems, at CTPark Jagodina in Serbia.

articleCtp N.v.May 19, 20253/company/ctp-nv-1/news/ctp-builds-18000-sqm-serbian-facility-for-schott-pharma-as-it-expands-global-manufacturing-network-1
CTP builds 18,000 sqm Serbian facility for SCHOTT Pharma as it expands global manufacturing network

About this update from Ctp N.v.

[{"type":"text","content":"AMSTERDAM, May 19, 2025--(BUSINESS WIRE)--Regulatory News:","length":58,"tagName":"p"},{"type":"text","content":"CTP, Europe's largest listed developer, owner, and manager of industrial and logistics properties by gross lettable area (GLA), has developed a new 18,000 sqm build-to-suit production facility for SCHOTT Pharma, a pioneer in pharma drug containment solutions and delivery systems, at CTPark Jagodina in Serbia.","length":314,"tagName":"p"},{"type":"text","content":"SCHOTT Pharma will produce high-quality glass ampoules for vaccines and other medications from the industrial property, which marks an expansion of the company’s global manufacturing network that now spans 15 countries.","length":219,"tagName":"p"},{"type":"text","content":"180 people will be employed at the facility, which complements SCHOTT Pharma’s 10 existing ampoule manufacturing sites across the globe, helping to safely deliver billions of injections every year. The property also benefits from CTP’s high-quality modern building standards and sustainability-focused design.","length":309,"tagName":"p"},{"type":"text","content":"CTPark Jagodina offers outstanding regional connectivity, located just off Serbia’s A1 highway and within reach of major cities including Belgrade (135 km), Niš (100 km), and multiple EU markets via direct road links. With a population of 400,000 within a 50 km radius and proximity to 20,000 students in nearby Kragujevac, the Park also provides access to skilled labour.","length":372,"tagName":"p"},{"type":"text","content":"CTPark Jagodina features energy-efficient buildings with BREEAM Very Good certifications, rooftop solar technology, water reuse systems, and modern amenities designed to support biodiversity and employee wellbeing. The park spans 22.9 hectares with 33,000 sqm of space already built, with 88,000 sqm planned for new development.","length":328,"tagName":"p"},{"type":"text","content":"Petar Kolognat, Business Development Director for CTP Serbia, commented:","length":72,"tagName":"p"},{"type":"text","content":""This partnership with SCHOTT Pharma is another shining example of how we support leading businesses in high-tech sectors by providing them with the strategic locations and scalable facilities they need. We are with our clients at every stage of their logistics property journeys, from site selection to...

More updates from Ctp N.v.

CTPSCHOTT PharmaSerbiaBelgradeproduction facilitySCHOTTglobal manufacturing networkJagodina